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The cardiovascular and prognostic significance of
the infrarenal aortic diameter
Paul E. Norman, MD,a Juanita Muller, MB BS,a and Jonathan Golledge, MD,b Fremantle, Western
Australia and Townsville, Queensland, Australia
The normal aortic diameter in adults usually ranges from 16 to 18 mm in women and 19 to 21 mm in men. Individuals
with diameters outside this range seem to be at increased risk of other cardiovascular disease. There is a graded association
between increasing aortic diameter and both cardiovascular mortality and peripheral arterial disease. The magnitude of
increased risk of cardiovascular death seems to be about 4% to 6% per mm increase over a diameter of about 23 mm. To
a lesser extent, these outcomes are also increased in individuals with aortic diameters below the normal range. While the
threshold of 3 cm is useful in the diagnosis of abdominal aortic aneurysm (AAA), it is arbitrary in terms of the vascular
biology and pathophysiology of the abdominal aorta. This review examines the risk factors for aortic enlargement and the
cardiovascular implications of this enlargement in patients with and without AAAs. The mechanisms underlying the
association between aortic diameter and cardiovascular risk and the relevance to screening are also discussed. (J Vasc Surg
2011;54:1817-20.)
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hNORMAL INFRARENAL AORTIC DIAMETER
RANGE AND CHANGE WITH AGE
Infrarenal aortic diameter has traditionally only been of
interest in the context of abdominal aortic aneurysms
(AAAs). The threshold diameter of 3 cm is commonly
accepted as indicating the presence of an AAA and 5 to 5.5
cm as indicating the need for intervention because of the
risk of rupture.1-4 Although these thresholds are very useful
for the clinical management of AAAs, they are arbitrary in
terms of the vascular biology and pathophysiology of the
abdominal aorta. To date, the priority has been to distin-
guish between nonaneurysmal and aneurysmal aortas, as
opposed to normal and abnormal aortic diameters. As such,
there are no consensus guidelines defining normal infrare-
nal aortic diameter. In addition to biological variables,
imaging modality and location within the infrarenal aorta
influence diameter measurements.
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doi:10.1016/j.jvs.2011.07.048Infrarenal aortic diameter, measured using ultrasound
canning in unselected adults, usually ranges from 16 to 18
m in women and 19 to 21 mm in men.1,5-8 Adjustment
or body habitus reduces these gender-related differences.
he normal infrarenal aortic diameter in men increases
rom about 8 mm at 5 years of age up to a median of about
1 mm in those aged 70 years and over.6,9,10 The concept
hat aortic diameter continues to increase with age has been
ecognized for over 100 years.11 Although the mean diam-
ter increases with advancing age, the median diameter
emains remarkably stable, particularly after the age of
5 years old, at about 21 mm in men and 20 mm in
omen.7,10,12 This is due to an increasingly right-
kewed distribution; only men with aortas in the top 25%
f diameters (15% for women) demonstrate progressive
ortic dilation with aging.13 These data suggest that an
ncrease in aortic diameter with aging may not be a
ormal phenomenon but may represent excessive cardio-
ascular risk, as discussed in the following sections.
ISK FACTORS FOR AORTIC ENLARGEMENT
The risk factors for AAAs have been extensively re-
orted and, in general, the pattern is similar to that seen in
cclusive atherosclerotic disease with the notable exception
f diabetes.14-16 Not surprisingly, the risk factors associated
ith enlarged, but nonaneurysmal, aortic diameters seem
o be similar to those for AAAs, although less has been
ublished on this. Apart from male gender and age (see
bove), various measures of body habitus, most commonly
eight, weight, or body mass index (BMI), have all been
ssociated with aortic diameter.6,14,17-21 Some studies sug-
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December 20111818 Norman et algest that body surface area is more strongly associated with
diameter than the other measures of body size.8,13,22
Gorter et al20 reported that, among participants with
clinically evident arterial disease in the Second Manifes-
tations of Arterial Disease Trial, both BMI and extent of
intra-abdominal fat were associated with increased aortic
diameter.
Smoking is independently associated with larger aortic
diameter, although dyslipidemia and hypertension have
limited influence.6,8 As with AAAs, white people seem to
have larger aortas than all other ethnic groups.8 The nega-
tive association between diabetes and both AAA presence
and expansion has also been reported with aortic diame-
ter,18,23 although this was not confirmed in a recent study.8
Even among nondiabetic individuals, there seems to be a
significant inverse correlation between fasting glucose con-
centration and aortic diameter throughout its range.18 The
mechanism responsible for the reduction of aortic dilation
by hyperglycemia is unknown but has been attributed to a
combination of enhanced deposition and reduced degrada-
tion of matrix as well as the consequences of advanced
glycation product deposition in the aortic wall.23,24
The associations between a wide range of circulating
biomarkers, including markers of lipid metabolism, inflam-
mation, matrix turnover and thrombosis, and both AAA
presence and progression has been previously reviewed.25
Few studies have examined the relationship between con-
centration of biomarker and diameter itself. In a recent
report from the Multi-Ethnic Study of Atherosclerosis,
only D-dimer (and not C-reactive protein, interleukin-6
[IL-6], fibrinogen, factor VIII, or homocysteine) was asso-
ciated with larger aortic diameter.8 As with most biomark-
ers, the question of causality remains unclear.
AORTIC DIAMETER AND RISK OF
CARDIOVASCULAR DISEASE
Cardiovascular mortality. The relationship between
aortic diameter and mortality from other cardiovascular
disease was initially recognized in patients with AAAs.
Aneurysmal diameter is an independent predictor of peri-
operative cardiovascular complications after either open or
endovascular repair.26-28 In a large multicenter study, Ko-
skas et al29 were the first to demonstrate that the diameter
of an AAA was an independent predictor of cumulative
5-year all-cause and cardiovascular mortality. During
follow-up in the United Kingdom Small Aneurysm Trial,
aneurysmal diameter was confirmed as an independent
predictor of all-cause mortality with a hazard ratio (HR) of
1.55 (95% confidence interval [CI], 1.14-2.1) per 1 cm
increase in aortic diameter.30 A further analysis of survival
in 2305 patients in this trial, found for every 8 mm increase
in aneurysm diameter, the hazard ratio for cardiovascular
mortality was 1.34 (95% CI, 1.01-1.79) during surveillance
and 1.31 (95% CI, 1.06-1.63) after surgery.31 Similar
results have been seen in studies that include endovascular
repairs.32 In the Cardiovascular Health Study, the risk of
cardiovascular mortality seemed to increase with aortic niameters over 30 mm or if the ratio of infrarenal to
uprarenal aortic diameter exceeded 1.4.33
In an extension of observations made in patients with
AAs, the relationship between aortic diameter in its non-
neurysmal range (30 mm) and cardiovascular disease
CVD) has been examined in a number of population-
ased cohorts. In the Cardiovascular Health Study, 4734
en and women aged 65 years had their aortic diameter
easured using an ultrasound scan; the HR for incident
ardiovascular events in participants with an aortic diameter
etween 20 and 30 mm was 1.17 (95% CI, 1.02-1.35)
ompared those with diameters below 20 mm.34 The rela-
ionship between aortic diameter and all-cause mortality
as reported in another study of 12,203 men aged 65
ears screened for AAAs.12 Aortic diameter below, or in
raded fashion above, the reference range of 19 to 22 mm
as an independent risk factor for all-cause mortality. This
ncluded a clear increase in risk among men without AAAs:
he HR was 1.26 (95% CI, 1.09-1.44) for diameters 23 to
6 mm and 1.35 (95% CI, 1.09-1.67) for diameters 27 to
0 mm.12 Most of the increased risk was due to cardiovas-
ular events other than those related to AAAs.35 There was
lso an increased risk for men with aortic diameters below
9 mm (HR, 1.23; 95% CI, 1.03-1.46). A similar relation-
hip between aortic diameter and cardiovascular mortality
as recently been confirmed in a 10-year follow-up of the
romsø study, in which 6640 men and women aged 25 to
4 years had their aortic diameter measured at baseline.
sing the diameter range 21 to 23mm as the reference, the
R for CVD mortality rose with both decreasing and
ncreasing diameters. For example, participants with en-
arged but nonaneurysmal aortas (27-29 mm) were at
ncreased risk with an HR of 1.86 (95% CI, 1.24-2.78) and
or those with aortas18 mm in diameter (HR, 1.18; 95%
I, 0.82-1.69).36
All these studies show that increasing aortic diameter is
marker of cardiovascular mortality. The magnitude of
ncreased risk of cardiovascular death seems to be about 4%
o 6% per mm increase over a diameter of about 23 mm.
he risk for individuals with aortic diameters below the
ormal range is also increased, although this is more diffi-
ult to quantify.
Peripheral arterial disease. Several studies have
hown that aortic diameter is also associated with peripheral
rterial disease (PAD). As part of the Second Manifesta-
ions of Arterial Disease Trial, 1572 patients aged 18 to 79
ears old with atherosclerotic disease had their aortic diam-
ters measured and were assessed for PAD (clinical assess-
ent and ankle brachial index). In a cross-sectional analysis
djusted for age and BMI, the prevalence of PAD in pa-
ients with diameters in the lower (8-15.9 mm) or upper
18-63 mm) tertiles was twice that of those in the middle
16-17.9 mm) tertile.37 In an analysis of 12,203 men
creened for AAAs in Western Australia, aortic diameter
ad the same relationship with prevalent claudication as
een for cardiovascular mortality.35 The adjusted HR for
revalent claudication for men with aortic diameters in the
onaneurysmal range of 23 to 29.9 mm was 1.24 (95% CI,
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In the Cardiovascular Health Study, increasing aortic diam-
eter predicted incident intermittent claudication, although,
due to a relatively low rate, the trend in the nonaneurysmal
range (20-30 mm vs the reference 20 mm) was not
significant with an HR of 1.25 (95% CI, 0.85-1.85).34
CAUSES FOR THE ASSOCIATION BETWEEN
DIAMETER AND GLOBAL CARDIOVASCULAR
RISK
The reason why both abnormally large (and small)
aortas are associated with adverse cardiovascular outcomes
is unknown. Much of the association is probably due to
shared risk factors and aortic diameter is just a surrogate
marker. Both large and small aortas may be associated with
chronic aortic wall changes such as increased stiffness and
calcification  resulting in adverse clinical consequences
such as hypertension, increased pulse pressure, and left
ventricular hypertrophy.8,38,39
There is evidence that enlarged aortas may be a source
of circulating inflammatory cytokines, which may contrib-
ute to remote cardiovascular events. For example, circulat-
ing IL-6 levels have been shown to positively correlate with
aortic diameter in individuals without aneurysms.8,40 In
addition, IL-6 concentrations have been reported to be
higher downstream to both abdominal and thoracic aneu-
rysms.41,42 These findings suggest that abnormally large
aortas may release proinflammatory cytokines into the cir-
culation, however, it is unknownwhether this is responsible
for the association with other CVDs.
Thrombus formation could also contribute to the in-
creased cardiovascular events by the release of thrombus
products, such as D-dimer or cytokines which have been
implicated in plaque destabilization.43 CirculatingD-dimer
concentrations are elevated in patients with aortic dilatation
and have been independently associated with cardiovascu-
lar events in patients with atherosclerosis.8,44,45 It has also
recently been shown that in patients with small AAAs, the
volume of intraluminal thrombus predicted subsequent
cardiovascular events independent of AAA diameter.46
CONCLUSIONS
In summary, aortic diameter is of more significance
than simply being used to diagnose an AAA. It is a marker
of other adverse cardiovascular outcomes. The ongoing
interest in the screening and risk assessment of asymptom-
atic individuals has been driven by evidence that primary
prevention of CVDmay be feasible.47 Current tools for the
assessment of CVD risk are imperfect and a significant
detection gap exists.48 The diameter of the infrarenal ab-
dominal aorta may have a role as a simple marker of global
cardiovascular risk. This applies not only to patients with
AAAs but also to those with small, or enlarged but nonan-
eurysmal, aortas.
The introduction of population screening for AAAs in
older men in the United States and a number of other
countries means that aortic diameter measurements will be
available at no additional cost or effort. The utility of thislinical information, over and above the detection of AAAs,
arrants further research but, at the very least, an individual
ound to have an aortic diameter outside the “normal” or
eference range should have their cardiovascular risk factors
ssessed. It remains to be established whether outcome can
e improved by modification of risk management on the
asis of diameter and consideration should be given to the
eed for a clinical trial to assess this.
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